on Nyxoah SA. (isin : BE0974358906)
Nyxoah Initiates Legal Action Against Inspire Medical Systems
Nyxoah SA, a Belgian medical technology firm focused on innovative treatments for Obstructive Sleep Apnea (OSA), announced it has filed a lawsuit against Inspire Medical Systems, Inc. Nyxoah claims that the Inspire IV and Inspire V devices infringe on its patents, specifically U.S. Patent Nos. 8,700,183, 9,415,215, and 9,415,216. The lawsuit, lodged in the U.S. District Court for the District of Delaware, seeks injunctive relief and damages.
Nyxoah's CEO, Olivier Taelman, emphasized the company’s commitment to defending its intellectual property, particularly highlighting its Genio® system. This system offers bi-lateral stimulation without traditional pacemaker hardware, is MRI compatible, and is designed to be upgradable without requiring additional surgeries.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Nyxoah SA. news